These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7130970)

  • 1. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1982; 54(3-4):145-51. PubMed ID: 7130970
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1983; 57(1-2):27-37. PubMed ID: 6619829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a "serotonergic syndrome" in neonatal rat pups?
    Ristine LA; Spear LP
    Pharmacol Biochem Behav; 1985 Feb; 22(2):265-9. PubMed ID: 2858868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the serotonin agonist, quipazine, on luteinizing hormone and prolactin release: evidence for serotonin-catecholamine interactions.
    Lynch CO; Johnson MD; Crowley WR
    Life Sci; 1984 Oct; 35(14):1481-7. PubMed ID: 6148678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of serotonergic drugs on the locomotor pattern and on cutaneous reflexes of the adult chronic spinal cat.
    Barbeau H; Rossignol S
    Brain Res; 1990 Apr; 514(1):55-67. PubMed ID: 2357531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quipazine exacerbation of a hyperkinetic syndrome: involvement of brain dopamine and serotonin.
    Langlais PJ; Gabay S
    J Neurosci Res; 1977; 3(2):135-41. PubMed ID: 563925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced head-twitch response to quipazine of rats previously treated with methiothepin: possible involvement of dopaminergic system.
    Dall'Olio R; Vaccheri A; Montanaro N
    Pharmacol Biochem Behav; 1985 Jul; 23(1):43-8. PubMed ID: 2994121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible dopamine agonist properties of quipazine maleate.
    Feigenbaum JJ; Yanai J; Klawans HL
    Int J Neurosci; 1983; 18(3-4):205-10. PubMed ID: 6222999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competition for sucrose-pellets in triads of male Wistar rats: effects of three serotonergic drugs.
    Gentsch C; Lichtsteiner M; Feer H
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):639-51. PubMed ID: 2975810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined effect of quipazine and haloperidol on plasma prolactin release.
    Feigenbaum J; Yanai J; Klawans HL; Chatterton R
    Int J Neurosci; 1983; 18(1-2):37-40. PubMed ID: 6840980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus properties of quipazine: direct serotonergic mediation.
    White FJ; Appel JB; Kuhn DM
    Neuropharmacology; 1979 Feb; 18(2):143-51. PubMed ID: 34803
    [No Abstract]   [Full Text] [Related]  

  • 15. Quipazine-induced behavior in neonatal rat pups.
    Spear LP; Ristine LA
    Pharmacol Biochem Behav; 1981 Jun; 14(6):831-4. PubMed ID: 7255519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical effects of quipazine on rat striatal dopaminergic system.
    Ponzio F; Consolazione A; Calderini G; Achilli G; Rocchetti M; Algeri S
    Life Sci; 1981 Jul; 29(1):83-91. PubMed ID: 7266263
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
    Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.